Efavirenz as a potential drug for the treatment of triple-negative breast cancers

Citation

Chiou, P, Ohms, S, Board, P et al. 2020, 'Efavirenz as a potential drug for the treatment of triple-negative breast cancers', Clinical and Translational Oncology, vol. 23, pp. 353-363.

Year

2020

Updated:  06 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers